• Specific Year
    Any

NATIONAL HEALTH ACT 1953 - SECT 85BA Effect of deemed reductions of, or increases to, approved ex - manufacturer price

NATIONAL HEALTH ACT 1953 - SECT 85BA

Effect of deemed reductions of, or increases to, approved ex - manufacturer price

  (1)   If, under a provision of this Part, the approved ex - manufacturer price of a brand of a pharmaceutical item is, or is taken to be, reduced by an amount (the reduction amount ) or a percentage (the reduction percentage ):

  (a)   in a case where a price agreement is in force in relation to the brand of the pharmaceutical item--the amount in force under the agreement as the amount that is, for the purposes of this Part, taken to be the appropriate maximum price of the brand of the pharmaceutical item is taken to be reduced by the reduction amount or the reduction percentage, as the case requires; or

  (b)   in a case where a price determination is in force in relation to the brand of the pharmaceutical item--the amount in force under the determination as the amount that is, for the purposes of this Part, taken to be the appropriate maximum price of the brand of the pharmaceutical item is taken to be reduced by the reduction amount or the reduction percentage, as the case requires.

  (2)   If, under a provision of this Part, the approved ex - manufacturer price of a brand of a pharmaceutical item is, or is taken to be, increased by an amount (the increase amount ) or a percentage (the increase percentage ):

  (a)   in a case where a price agreement is in force in relation to the brand of the pharmaceutical item--the amount in force under the agreement as the amount that is, for the purposes of this Part, taken to be the appropriate maximum price of the brand of the pharmaceutical item is taken to be increased by the increase amount or the increase percentage, as the case requires; or

  (b)   in a case where a price determination is in force in relation to the brand of the pharmaceutical item--the amount in force under the determination as the amount that is, for the purposes of this Part, taken to be the appropriate maximum price of the brand of the pharmaceutical item is taken to be increased by the increase amount or the increase percentage, as the case requires.